Cite
miR‐223 improves intestinal inflammation through inhibiting the IL‐6/STAT3 signaling pathway in dextran sodium sulfate‐induced experimental colitis.
MLA
Zhang, Juanjuan, et al. “MiR‐223 Improves Intestinal Inflammation through Inhibiting the IL‐6/STAT3 Signaling Pathway in Dextran Sodium Sulfate‐induced Experimental Colitis.” Immunity, Inflammation & Disease, vol. 9, no. 1, Mar. 2021, pp. 319–27. EBSCOhost, https://doi.org/10.1002/iid3.395.
APA
Zhang, J., Wang, C., Guo, Z., Da, B., Zhu, W., & Li, Q. (2021). miR‐223 improves intestinal inflammation through inhibiting the IL‐6/STAT3 signaling pathway in dextran sodium sulfate‐induced experimental colitis. Immunity, Inflammation & Disease, 9(1), 319–327. https://doi.org/10.1002/iid3.395
Chicago
Zhang, Juanjuan, Chenyang Wang, Zhen Guo, Binlin Da, Weiming Zhu, and Qiurong Li. 2021. “MiR‐223 Improves Intestinal Inflammation through Inhibiting the IL‐6/STAT3 Signaling Pathway in Dextran Sodium Sulfate‐induced Experimental Colitis.” Immunity, Inflammation & Disease 9 (1): 319–27. doi:10.1002/iid3.395.